Q1 2020 Endo International PLC Earnings Call Transcript
Good morning. My name is Lisa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2020 Endo International Earnings Conference Call. (Operator Instructions) I would now like to turn the call over to Ms. Laure Park, Senior Vice President, Investor Relations and Corporate Affairs. Please go ahead, ma'am.
Good morning, and thank you for joining us to discuss our first quarter 2020 financial results. Joining me on today's call are Blaise Coleman, President and CEO of Endo; Mark Bradley, Executive Vice President and CFO; Pat Barry, President, Global Commercial Operations; and Domenic Ciarico, Chief Commercial Officer of Sterile Injectables and Generics. We've prepared a slide presentation to accompany today's webcast, and that presentation as well as other materials are posted online in the Investors section at endo.com.
I would like to remind you that any forward-looking statements made by management are covered under the U.S.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |